CIK 0001655759 · Accelerated filer
ARVINAS, INC.
Sign in to watch- Ticker
- ARVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472566120
- Phone
- 203-535-1456
- Business address
- 395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, 06511
- Former names
- ARVINAS INC., ARVINAS HOLDING COMPANY, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,475
- in 1 filing, $1K under 10b5-1 plans
Net −$1,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-01 | Houston John G President and CEO | Option exercise | +17,510 | 923,305 | ||
| 2023-03-01 | Houston John G President and CEO | Sale | −5,878 | $29.53 | $174K | 917,427 |
| 2023-03-01 | Houston John G President and CEO | Option exercise · Restricted Stock Units | −17,510 | 0 | ||
| 2023-03-01 | Cassidy Sean A Chief Financial Officer | Option exercise | +4,791 | 185,363 | ||
| 2023-03-01 | Cassidy Sean A Chief Financial Officer | Sale | −1,745 | $29.53 | $52K | 183,618 |
| 2023-03-01 | Cassidy Sean A Chief Financial Officer | Option exercise · Restricted Stock Units | −4,791 | 0 | ||
| 2023-02-22 | Cassidy Sean A Chief Financial Officer | Grant or award | +19,125 | 180,572 | ||
| 2023-02-22 | Cassidy Sean A Chief Financial Officer | Grant or award · Stock Option (right to buy) | +57,450 | 57,450 | ||
| 2023-02-22 | Peck Ronald Chief Medical Officer | Grant or award | +19,125 | 27,279 | ||
| 2023-02-22 | Peck Ronald Chief Medical Officer | Grant or award · Stock Option (right to buy) | +57,450 | 57,450 | ||
| 2023-02-22 | Houston John G President and CEO | Grant or award | +61,975 | 905,795 | ||
| 2023-02-22 | Houston John G President and CEO | Grant or award · Stock Option (right to buy) | +186,250 | 186,250 | ||
| 2023-02-22 | Taylor Ian Chief Scientific Officer | Grant or award | +19,125 | 100,087 | ||
| 2023-02-22 | Taylor Ian Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +57,450 | 57,450 | ||
| 2022-12-15 | Cunningham Everett Director | Grant or award · Common Stock | +30,095 | 30,095 | ||
| 2022-08-18 | YOUNG JOHN D Director | Grant or award · Stock Option (right to buy) | +24,572 | 24,572 | ||
| 2022-08-12 | Peck Ronald Chief Medical Officer | Option exercise | +4,010 | 9,412 | ||
| 2022-08-12 | Peck Ronald Chief Medical Officer | Sale | −1,258 | $54.84 | $69K | 8,154 |
| 2022-08-12 | Peck Ronald Chief Medical Officer | Option exercise · Restricted Stock Units | −4,010 | 4,010 | ||
| 2022-08-12 | Peck Ronald Chief Medical Officer | Option exercise | +4,010 | 9,412 |
Page 9 of 10 · 184 trades